Rt-PA in the Treatment of Acute Ischemic Stroke
NCT00153036
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
821
Enrollment
INDUSTRY
Sponsor class
Conditions
Cerebrovascular Accident
Interventions
DRUG:
rt-PA 0.9 mg/kg verum or placebo Intravenous
Sponsor
Boehringer Ingelheim